Full Press Release Details
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022.
VKTX
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022
Key Takeaway: Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022
Price reaction · baseline $3.83 (2022-02-01 close) · hit after-hours · 1 other VKTX headline(s) in the window, move may be shared
day 0 close
-6.8%
day 1 · peak
-10.4%
day 3
-5.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss